Berenberg Bank analyst Victoria Lambert maintained a Buy rating on Fresenius Medical Care AG & Co. KGaA (0H9X – Research Report) yesterday ...

Marianne Bulot, an analyst from Bank of America Securities, reiterated the Hold rating on Fresenius Medical Care AG & Co. KGaA (0H9X – ...

Fistula monitoring system developer for dialysis patients PatenSee has signed a clinical collaboration agreement with Fresenius Medical Care. The companies will conduct a joint, multi-centre pilot ...

Underlying demographic trends and international expansion opportunities should keep help Fresenius Medical Care's dialysis services and related medical product growth in positive territory as the ...

Fresenius Medical Care AG (NYSE:FMS – Get Free Report) shares reached a new 52-week high during mid-day trading on Friday . The stock traded as high as $24.35 and last traded at $24.25, with a volume ...

Our nephrologists provide dialysis at Fresenius Medical Care, U.S. Renal Care, and DaVita outpatient facilities throughout the Portland metropolitan area, Southwest Washington, and the Columbia River ...

Fresenius Medical Care AG& Co FMS announced the launch of the newest version of its home dialysis machine, NxStage Versi HD, ...

TSN, GM, FMS and DLX boast a low P/CF ratio. Fresenius Medical Care leads global dialysis services, driving growth through innovation, restructuring and a strong global footprint in 120+ countries.

8.37% of the stock is owned by institutional investors and hedge funds. Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North ...

Dialysis in a clinic began in October 2023 ... Waiting for a transplant Fresenius Medical Care staff provides training and support. Ray Dupilka said it took a few weeks of training to get ...